Security

CTTH · CTT PHARMACEUTICAL HOLDINGS, INC.

CTTHOTCCommon stockCurrentCIK 1035422Updated Sep 29, 2026

Company: CTT PHARMACEUTICAL HOLDINGS, INC. →

Name history

Mindesta Inc. · through Jul 21, 2015INDUSTRIAL MINERALS INC · through Jul 18, 2011PNW CAPITAL INC · through May 21, 2002WINCHESTER MINING CORP · through May 26, 2000

CTTH price & chart

Provider market data

Loading TradingView…

OTC:CTTH on TradingView ↗

TradingView · Data may be delayed

About the company

CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in oral drug delivery systems designed to provide rapid onset, enhanced patient convenience, and efficient absorption. The Company’s patented micelle based thin film platform is intended to offer a novel alternative to traditional dosage forms across pharmaceutical, therapeutic, and nutraceutical markets. CTT is focused on integrating scientific validation, scalable manufacturing, and regulatory preparedness to support long-term growth and product innovation.

8-K · 2026-08-12 · 0001171520-26-000225

Company description from the cited filing.

In the news

No coverage from other publishers is available.

SEC disclosures

CTT PHARMACEUTICAL HOLDINGS, INC. files 8-K: Material Event ↗

SEC · 2026-09-22

CTT PHARMACEUTICAL HOLDINGS, INC. files 8-K: Material Event ↗

SEC · 2026-08-12

CTT PHARMACEUTICAL HOLDINGS, INC. IPO declared effective by SEC ↗

SEC · 2026-08-03

Recent filings

4/A filing
4/A · 2026-09-29 · 0001035422-26-000015
4 filing
4 · 2026-09-28 · 0001035422-26-000014
Entry into a Material Definitive Agreement · Other Events
Items 1.01, 8.01, 9.01
8-K · 2026-09-23 · 0001477932-26-005750
4 filing
4 · 2026-09-22 · 0001035422-26-000013
10-Q filing
10-Q · 2026-09-17 · 0001477932-26-005663

Show 5 more recent filings

4 filing
4 · 2026-09-16 · 0001035422-26-000012
4 filing
4 · 2026-09-10 · 0001035422-26-000011
4 filing
4 · 2026-09-04 · 0001035422-26-000010
4 filing
4 · 2026-09-02 · 0001035422-26-000009
4 filing
4 · 2026-08-31 · 0001035422-26-000008

Financials

FY 2014 · USD

Revenue— · FY 2014

Net income-672,162USD · FY 2014

Source

10-K/A · 2015-10-08 · 0001553350-15-001055

2014-01-01 to 2014-12-31

Assets1,662,370USD · FY 2014

Source

10-K · 2015-04-14 · 0001553350-15-000347

As of 2014-12-31

Cash81,179USD · FY 2014

Source

10-K · 2015-04-14 · 0001553350-15-000347

As of 2014-12-31

Operating income-672,162USD · FY 2014

Source

10-K · 2015-04-14 · 0001553350-15-000347

2014-01-01 to 2014-12-31

Diluted EPS— · FY 2014

Some figures are unavailable for this reporting year.

balance sheet · annual statements

Line item	FY 2014	FY 2013	FY 2012	FY 2011
ASSETS
AssetsUSD	1,662,370 Source 10-K · 2015-04-14 · 0001553350-15-000347 As of 2014-12-31	6,252 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	203,079 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	4,182,995 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Property, Plant and Equipment, NetUSD	—	—	—	0 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD	81,179 Source 10-K · 2015-04-14 · 0001553350-15-000347 As of 2014-12-31	823 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	12,091 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	569,378 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Accounts Receivable, after Allowance for Credit Loss, CurrentUSD	5,430 Source 10-K · 2015-04-14 · 0001553350-15-000347 As of 2014-12-31	—	—	—
Assets, CurrentUSD	1,049,734 Source 10-K · 2015-04-14 · 0001553350-15-000347 As of 2014-12-31	6,252 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	203,079 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	750,734 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
LIABILITIES AND EQUITY
LiabilitiesUSD	169,490 Source 10-K/A · 2015-10-08 · 0001553350-15-001055 As of 2014-12-31	249,378 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	589,413 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	3,726,545 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Commitments and ContingenciesUSD	—	0 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	—	—
Stockholders’ equity:
Common Stock, Value, IssuedUSD	1,951 Source 10-K/A · 2015-10-08 · 0001553350-15-001055 As of 2014-12-31	18,817 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	18,817 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	18,592 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Additional Paid in CapitalUSD	145,729 Source 10-K/A · 2015-10-08 · 0001553350-15-001055 As of 2014-12-31	12,663,857 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	12,626,129 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	12,537,316 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Retained Earnings (Accumulated Deficit)USD	-867,362 Source 10-K/A · 2015-10-08 · 0001553350-15-001055 As of 2014-12-31	—	—	—
Accumulated Other Comprehensive Income (Loss), Net of TaxUSD	-1,069 Source 10-K · 2015-04-14 · 0001553350-15-000347 As of 2014-12-31	0 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	4,984 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	-105,985 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Stockholders' Equity Attributable to ParentUSD	1,492,880 Source 10-K/A · 2015-10-08 · 0001553350-15-001055 As of 2014-12-31	-243,126 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	-386,334 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	456,450 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Liabilities and EquityUSD	1,662,370 Source 10-K · 2015-04-14 · 0001553350-15-000347 As of 2014-12-31	6,252 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	203,079 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	4,182,995 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Current liabilities:
Liabilities, CurrentUSD	—	249,378 Source 10-K · 2014-02-10 · 0001062993-14-000591 As of 2013-12-31	589,413 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	3,726,545 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Stockholders' Equity Attributable to Noncontrolling InterestUSD	—	—	—	0 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Additional Financial Items
Dividends Payable, CurrentUSD	—	—	0 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	3,274,072 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements

Line item	FY 2014	FY 2013	FY 2012	FY 2011
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	—	—	—	—
Share-based Payment Arrangement, Noncash ExpenseUSD	308,439 Source 10-K · 2015-04-14 · 0001553350-15-000347 2014-01-01 to 2014-12-31	0 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	42,268 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	155,396 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Net Cash Provided by (Used in) Operating ActivitiesUSD	-72,250 Source 10-K · 2015-04-14 · 0001553350-15-000347 2014-01-01 to 2014-12-31	-136,229 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	-1,027,011 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	-316,132 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD	151,891 Source 10-K · 2015-04-14 · 0001553350-15-000347 2014-01-01 to 2014-12-31	124,961 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	435,974 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	877,007 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD	—	0 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	33,750 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	-37,688 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Additional Financial Items
Deconsolidation, Gain (Loss), AmountUSD	—	—	0 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	6,035,839 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Dividends Payable, CurrentUSD	—	—	0 Source 10-K · 2013-03-08 · 0001062993-13-001090 As of 2012-12-31	3,274,072 Source 10-K · 2012-03-20 · 0001204459-12-000549 As of 2011-12-31
Foreign Currency Transaction Gain (Loss), before TaxUSD	—	-7,700 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	-6,206 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	-19,021 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Gain (Loss) on Extinguishment of DebtUSD	—	—	0 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	0 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
General and Administrative ExpenseUSD	17,641 Source 10-K · 2015-04-14 · 0001553350-15-000347 2014-01-01 to 2014-12-31	-160,382 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	158,353 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	316,408 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Income (Loss) from Equity Method InvestmentsUSD	—	—	0 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	-1,518,789 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Net Income (Loss) Attributable to ParentUSD	-672,162 Source 10-K/A · 2015-10-08 · 0001553350-15-001055 2014-01-01 to 2014-12-31	110,464 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	-1,003,188 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	3,738,515 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Net Income (Loss) Attributable to Noncontrolling InterestUSD	—	—	—	0 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Operating ExpensesUSD	672,162 Source 10-K · 2015-04-14 · 0001553350-15-000347 2014-01-01 to 2014-12-31	-92,201 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	1,194,907 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	757,935 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Proceeds from Stock Options ExercisedUSD	—	0 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	33,750 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	101,250 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements

Line item	FY 2014	FY 2013	FY 2012	FY 2011
Operating Income (Loss)USD	-672,162 Source 10-K · 2015-04-14 · 0001553350-15-000347 2014-01-01 to 2014-12-31	92,201 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	-1,194,907 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	-757,935 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Net Income (Loss) Attributable to Noncontrolling InterestUSD	—	—	—	0 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Net Income (Loss) Attributable to ParentUSD	-672,162 Source 10-K/A · 2015-10-08 · 0001553350-15-001055 2014-01-01 to 2014-12-31	110,464 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	-1,003,188 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	3,738,515 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Earnings Per Share, BasicUSD per share	—	0.01 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	-0.11 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	0.42 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Earnings Per Share, DilutedUSD per share	—	0.01 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	-0.11 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	0.4 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Weighted Average Number of Shares Outstanding, Basicshares	—	9,413,581 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	9,412,659 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	8,920,635 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Weighted Average Number of Shares Outstanding, Dilutedshares	—	9,413,581 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	9,412,659 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	9,492,485 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Additional Financial Items
Depreciation, Depletion and Amortization, NonproductionUSD	—	—	—	0 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Foreign Currency Transaction Gain (Loss), before TaxUSD	—	-7,700 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	-6,206 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	-19,021 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
General and Administrative ExpenseUSD	17,641 Source 10-K · 2015-04-14 · 0001553350-15-000347 2014-01-01 to 2014-12-31	-160,382 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	158,353 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	316,408 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Income (Loss) from Equity Method InvestmentsUSD	—	—	0 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	-1,518,789 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Interest and Other IncomeUSD	—	1,645 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	53 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	6,671 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31
Marketing and Advertising ExpenseUSD	126,760 Source 10-K · 2015-04-14 · 0001553350-15-000347 2014-01-01 to 2014-12-31	—	—	—
Operating ExpensesUSD	672,162 Source 10-K · 2015-04-14 · 0001553350-15-000347 2014-01-01 to 2014-12-31	-92,201 Source 10-K · 2014-02-10 · 0001062993-14-000591 2013-01-01 to 2013-12-31	1,194,907 Source 10-K · 2013-03-08 · 0001062993-13-001090 2012-01-01 to 2012-12-31	757,935 Source 10-K · 2012-03-20 · 0001204459-12-000549 2011-01-01 to 2011-12-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-292497

S-1/A · 2026-07-24 · 0001171520-26-000192

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

ex99-1.htm · 8-K · 2026-08-12

EX-99.1 2 ex99-1.htm PRESS RELEASE Exhibit 99.1 CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology NEWSWIRE - August 10, 2026 - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the company has been formally approved by the U.S. Patent Office for a continuation-in-part (CIP). A continuation-in-part (CIP) patent is a new application that repeats a substantial portion of an earlier “parent” application while adding brand new …

8-K · 2026-08-12 · 0001171520-26-000225

Read attachment ↗